🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Opioid-Related Disorders

Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 3 NCT07793383NA3 sites📍 Guilford📍 New Haven📍 New Haven Yale University · Tests: Refined EMBED CDS, Provider alert that nurse completed COWS Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Disorder Treatment NCT07197801NA1 site📍 Danville Geisinger Clinic · Tests: Peer recovery support to enhance patient engagement in medication for opioid use disorder treatment Teaching Health Resilience in a Hospital Setting: A Peer-led Intervention NCT06843213NA3 sites📍 Pittsburgh📍 Pittsburgh📍 Pittsburgh University of Pennsylvania · Tests: Peer Intervention, Enhanced Usual Care Mindfulness Texting for Medication Adherence and Chronic Pain Management NCT07711795NA1 site📍 Albuquerque University of New Mexico · Tests: Mindfulness text messages Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes NCT03923374n/a1 site📍 Pittsburgh Senthil Sadhasivam · Tests: Subutex / Buprenorphine, Fetal & Neonatal MRI, DNA/Genetic/Pharmacokenetic Blood Draws Brief Digitally-Enhanced Intervention for Reducing Alcohol Use During MOUD NCT06718491NA1 site📍 Columbus Ohio State University · Tests: Managing Physical Reactions to Overwhelming Emotions (IMPROVE), Health Education Training (HET) MATAspire: Mental Health Awareness Tailored App for Substance Prevention and Integrated Resilience Education NCT06553196NA1 site📍 Northridge California State University, Northridge · Tests: MATAspire Web-app CARES (Comprehensive Analgesic, Recovery, and Education Support) for Surgery Trial NCT06027099Phase 34 sites📍 Stanford📍 Kansas City📍 Boston Stanford University · Tests: Tizanidine, MI-Opioid Taper, Placebo, Enhanced Usual Care Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects NCT06981195Phase 21 site📍 Richmond Virginia Commonwealth University · Tests: Placebo, Lemborexant 10 MG Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder NCT06067737Phase 21 site📍 Baltimore Johns Hopkins University · Tests: Psilocybin, Psilocybin Clinical Decision Support to Increase Use of Medications for Opioid Use Disorder NCT06526286n/a1 site📍 Aurora University of Colorado, Denver · Tests: Medications for Opioid Use Disorder Pathway Clinical Decision Support (CDS) Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses NCT07631598NA8 sites📍 Los Angeles📍 Washington D.C.📍 Baton Rouge Montefiore Medical Center · Tests: Standard of Care Referral, Low Threshold Buprenorphine A Clinical Trial Comparing Buprenorphine Formulations for High Potency Synthetic Opioid Use NCT06726200EARLY Phase 11 site📍 New York Rachel R. Luba · Tests: Buprenorphine + naloxone (Suboxone), Buprenorphine Injection Real-time Opioid Study NCT07768007NA1 site📍 New Haven Yale University · Tests: real-time functional magnetic resonance imaging (rt-fMRI) neurofeedback Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications. NCT06617949EARLY Phase 12 sites📍 Milwaukee📍 Milwaukee Medical College of Wisconsin · Tests: Regional Anesthesia, Hydromorphone Patient Controlled Analgelsic, Epidural local anesthetic infusion Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data NCT06768814NA1 site📍 Seattle University of Washington · Tests: Sub-acute stabilization Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder NCT06487533n/a2 sites📍 Center City📍 Columbus Spark Biomedical, Inc. · Tests: EmbracePlus Smartwatch, Corti Sensor Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention NCT05973838NA4 sites📍 Washington D.C.📍 Baltimore📍 College Park University of Maryland, College Park · Tests: Peer-Delivered Behavioral Activation ("Peer Activate") Measuring Acute Drug Demand in Humans NCT05829655EARLY Phase 11 site📍 Baltimore University of Maryland, Baltimore · Tests: Drug A (Blinded Drug), Drug B (Blinded Drug), Drug C (Blinded Drug), Drug D (Blinded Drug), Suvorexant (20mg/day) Cannabis and Opioid Use Disorder NCT05729932Phase 11 site📍 Lexington Shanna Babalonis, PhD · Tests: Inhaled vaporized cannabis, Intransal opioid Imaging CRF X NOP Interactions in Alcohol Use Disorder NCT07612631EARLY Phase 11 site📍 Pittsburgh Rajesh Narendran · Tests: Baseline [C-11]NOP-1A PET scan, Hydrocortisone, Post-hydrocortisone [C-11]NOP-1A PET scan Ketamine Assisted Psychotherapy for Opioid Use Disorder NCT04892251Phase 1, Phase 21 site📍 Salt Lake City University of Utah · Tests: MORE+KAP, MORE Optimization of NIBS for Treatment of Addiction NCT04379115NA3 sites📍 Hinsdale📍 Cambridge📍 Cleveland Case Western Reserve University · Tests: Active Comparator: Active tDCS + Active TUS, Sham Comparator: Sham tDCS + Sham TUS Injectable Buprenorphine in Prison: A Preference Trial NCT06880718Phase 41 site📍 Cranston Lifespan · Tests: Brixadi (Injectable Buprenorphine), Sublocade Symptom-Inhibited Naloxone Induction (SINI) for Buprenorphine Initiation: A Feasibility Trial NCT07439549Phase 42 sites📍 Vancouver📍 Vancouver Pouya Azar · Tests: Naloxone Hydrochloride 0.4 MG/ML, Buprenorphine hydrochloride and naloxone hydrochloride dihydrate sublingual tablet (2… Adversity, Brain and Opioid Use Study NCT06355778NA1 site📍 Ann Arbor University of Michigan · Tests: Magnetic Resonance Imaging (MRI), Computer Tasks Reducing Overdose and Substance Use-related Stigma by Training Non-substance-using Friends and Family Members of People Who Use Opioids to Be Harm Reduction Champions NCT06823453NA1 site📍 Chicago University of Illinois at Chicago · Tests: Peer Harm Reduction Support Champion Intervention Better Options for Chronic Cancer Pain NCT06574009Phase 42 sites📍 Indianapolis📍 Ann Arbor VA Office of Research and Development · Tests: Multimodal pain care, Medication optimization, Buprenorphine rotation, Opioid tapering Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder NCT06538558Phase 11 site📍 Indianapolis Proniras Corporation · Tests: Tezampanel, Placebo Clinical Trials of Multivalent Opioid Vaccine Components NCT04458545Phase 1, Phase 22 sites📍 Eatontown📍 New York New York State Psychiatric Institute · Tests: Oxy(Gly)4-sKLH vaccine - Low Dose, Oxy(Gly)4-sKLH vaccine - High Dose, Placebo Oxy(Gly)4-sKLH vaccine
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy